Human platelets respond differentially to lysophosphatidic acids having a highly unsaturated fatty acyl group and alkyl ether-linked lysophosphatidic acids

Biochemical Journal

Volumn 365, Issue 3, 2002, Pages 617-628

  Tokumura, Akira ^a   Sinomiya, Junya ^a   Kishimoto, Seishi ^a   Tanaka, Tamotsu ^a   Kogure, Kentaro ^a   Sugiura, Takayuki ^a   Satouchi, Kiyoshi ^a   Waku, Keizo ^a   Fukuzawa, Kenji ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Bovine serum albumin; Lysophosphatidylcholine; Platelet aggregation; Positional isomer

Indexed keywords

BLOOD; CELLS; DERIVATIVES; ENZYMES; ISOMERS; RNA;

PLASMA MEMBRANES;

ACIDS;

2 (4 AMYLCINNAMIDO) 4 CHLOROBENZOIC ACID; BOVINE SERUM ALBUMIN; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDYLCHOLINE;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FAST ATOM BOMBARDMENT MASS SPECTROMETRY; HUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

AFFINITY LABELS; AMINOBENZOIC ACIDS; ANIMALS; BLOOD PLATELETS; CATTLE; CINNAMATES; DOSE-RESPONSE RELATIONSHIP, DRUG; FATTY ACIDS, UNSATURATED; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GLYCERYL ETHERS; HUMANS; LYSOPHOSPHOLIPIDS; MOLECULAR STRUCTURE; NUCLEAR PROTEINS; PHOSPHODIESTERASE INHIBITORS; PLATELET AGGREGATION; RECEPTORS, CELL SURFACE; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, LYSOPHOSPHATIDIC ACID; SERUM ALBUMIN, BOVINE; TRANSCRIPTION FACTORS;

ANIMALIA; BOVINAE;

EID: 0036683314     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20020348     Document Type: Article

References (58)

1. Growth factor-like effects of lysophosphatidic acid, a novel lipid mediator
2. A family of phospholipid autacoids: Occurrence, metabolism and bioactions
3. Diversity of cellular receptors and functions for the lysophospholipid growth factors lysophosphatidic acid and sphingosine 1-phosphate
4. Functions of a new family of sphingosine-1-phosphate receptors
5. Evidence that the cannabinoid CB1 receptor is a 2-arachidonoylglycerol receptor. Structure-activity relationship of 2-arachidonoylglycerol, ether-linked analogues, and related compounds
6. Lysophosphatidic acid as a phospholipid mediator: Pathways of synthesis
7. Quantification, characterization and fatty acid composition of lysophosphatidic acid in different rat tissues
8. Occurrence of lysophosphatidic acid and its alkyl ether-linked analog in rat brain and composition of their biological activities toward cultured neuronal cells
9. Electrospray ionization mass spectrometry analysis of lysophospholipids in human ascitic fluids: Comparison of the lysophospholipid contents in malignant vs nonmalignant ascitic fluids
10. Growth factor-like phospholipid generated after corneal injury
11. Lysophospholipid receptors: Implications for neural signaling
12. Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid
13. Involvement of lysophospholipase D in the production of lysophosphatidic acid in rat plasma
14. Production of lysophosphatidic acids by lysophospholipase D in human follicular fluids in vitro fertilization patients
15. Production of lysophosphatidic acid by lysophospholipase D in incubated plasma of spontaneously hypertensive rats and Wistar Kyoto rats
16. Substrate specificity of lysophospholipase D which produces bioactive lysophosphatidic acids in rat plasma
17. Direct quantitative analysis of lysophosphatidic acid molecular species by stable isotope dilution electrospray ionization liquid chromatography-mass spectrometry
18. Fatty acid composition of lysophosphatidic acid and lysophosphatidylinositol in plasma from patients with ovarian cancer and other gynecological diseases
19. Identification of the molecular species of lysophosphatidic acid produced when platelets are stimulated by thrombin
20. Characterization of plasma unsaturated lysophosphatidylcholines in human and rat
21. Effects of synthetic and natural lysophosphatidic acids on the arterial blood pressure of different animal species
22. 2+ mobilization in human A431 cells: Structure-activity analysis
23. Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species. Structure-activity relationship of cloned LPA receptors
24. Dietary fatty acids - The n-6/n-3 balance and chronic elderly diseases. Excess linoleic acid and relative n-3 deficiency syndrome seen in Japan
25. The bioactive phospholipid lysophosphatidic acid is released from activated platelets
26. Lysophosphatidic acids induces proliferation of cultured vascular smooth muscle cells from rat aorta
27. Effects of lysophosphatidic acids and their structural analogs on arterial blood pressure of cats
28. Biochemical characterization of the interaction of lipid phosphoric acids with human platelets: Comparison with platelet activating factor
29. Activation of phospholipase A and C in human platelets exposed to epinephrine: Role of glycoproteins IIb/IIIa and dual role of epinephrine
30. 1 activity for its production
31. Synthesis of fatty acid anhydrides by reaction with dicyclohexylcarbodiimide
32. Evidence for production of 1-acyl-2-acetyl-sn-glyceryl-3-phosphorylcholine concomitantly with platelet-activating factor
33. A rapid method of total lipid extraction and purification
34. Analyses of lysophosphatidic acids by gas chromatography mass spectrometry without hydrolytic pretreatment
35. Determination of lipid phosphorus in the nanomolar range
36. The human platelet as a reproducible and sensitive cell for the detection and assay of platelet-activating factor
37. Regulation by IL-5 of expression of functional platelet-activating factor receptors on human eosinophils
38. Human platelet aggregation induced by 1-alkyl-lysophosphatidic acid and its analogs: A new group of phospholipid mediator?
39. Platelet aggregation induced by ether-linked phospholipids. 1. Inhibitory actions of bovine serum albumin and structural analogues of platelet activating factor
40. Lysophosphatidates bound to serum albumin activate membrane currents in Xenopus oocytes and neurite retraction in PC12 pheochromocytoma cells
41. The binding of lysophospholipids to rat liver fatty acid-binding protein and albumin
42. N-Palmitoyl-serine and N-palmitoyl-tyrosine phosphoric acids are selective competitive antagonists of the lysophosphatidic acid receptors
43. Characterization of a receptor subtype-selective lysophosphatidic acid mimetic
44. Acyl and phosphoryl migration in lysophospholipids: Importance in phospholipid synthesis and phospholipase specificity
45. Platelet aggregation evoked in vitro and in vivo by phosphatidic acids and lysoderivatives: Identity with substances in aged serum (DAS)
46. Lysophosphatidic acids. Influence on platelet aggregation and intracellular calcium flux
47. Lysophosphatidic acid-induced aggregation of human and feline platelets: Structure-activity relationship
48. Identification of lysophospholipid receptors in human platelets: The relation of two agonists, lysophosphatidic acid and sphingosine 1-phosphate
49. Structure-activity analysis of the effects of lysophosphatidic acid on platelet aggregation
50. 2+ spiking in vascular smooth muscle cells involves phospholipase D
51. The uptake and metabolism of plasma lysophosphatidylcholine in vivo by the brain of squirrel monkeys
52. Metabolism of lysolecithin in vivo and in vitro with particular emphasis on the arterial wall
53. Phosphatidylcholine formation from exogenous lysophosphatidylcholine in isolated hamster heart
54. Unsaturated fatty acids esterified in 2-acyl-1-lysophosphatidylcholine bound to albumin are more efficiently taken up by the young rat brain than the unesterified form
55. Lysophosphatidic acid as a regulator of endothelial/leukocyte interaction
56. Lysophosphatidic acid increases tight junction permeability in cultured brain endothelial cells
57. Role of oxidized low density lipoprotein in atherosclerosis
58. Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions